The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum

Overview of attention for article published in Frontiers in Pharmacology, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 42 X posts from 15 X users, with an upper bound of 228,208 followers.

RT @niche_science: With the MHRA considering the responses to the public consultation on proposals for legislative changes for clinical tri…

RT @niche_science: With the MHRA considering the responses to the public consultation on proposals for legislative changes for clinical tri…

RT @niche_science: With the MHRA considering the responses to the public consultation on proposals for legislative changes for clinical tri…

RT @niche_science: With the MHRA considering the responses to the public consultation on proposals for legislative changes for clinical tri…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 38 additional X posts.